These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 15717310

  • 1. Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancer.
    Ueda T, Komiya A, Suzuki H, Shimbo M, Sakamoto S, Imamoto T, Akakura K, Shiraishi T, Ichikawa T.
    Prostate; 2005 Aug 01; 64(3):265-71. PubMed ID: 15717310
    [Abstract] [Full Text] [Related]

  • 2. Identification of a I-cM region of common deletion on 13q14 associated with human prostate cancer.
    Ueda T, Emi M, Suzuki H, Komiya A, Akakura K, Ichikawa T, Watanabe M, Shiraishi T, Masai M, Igarashi T, Ito H.
    Genes Chromosomes Cancer; 1999 Mar 01; 24(3):183-90. PubMed ID: 10451697
    [Abstract] [Full Text] [Related]

  • 3. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
    Kawana Y, Ichikawa T, Suzuki H, Ueda T, Komiya A, Ichikawa Y, Furuya Y, Akakura K, Igarashi T, Ito H.
    Prostate; 2002 Sep 15; 53(1):60-4. PubMed ID: 12210480
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
    Latil A, Cussenot O, Fournier G, Driouch K, Lidereau R.
    Cancer Res; 1997 Mar 15; 57(6):1058-62. PubMed ID: 9067271
    [Abstract] [Full Text] [Related]

  • 8. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
    Latil A, Cussenot O, Fournier G, Baron JC, Lidereau R.
    Clin Cancer Res; 1995 Nov 15; 1(11):1385-9. PubMed ID: 9815935
    [Abstract] [Full Text] [Related]

  • 9. Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer.
    Komiya A, Suzuki H, Ueda T, Yatani R, Emi M, Ito H, Shimazaki J.
    Genes Chromosomes Cancer; 1996 Dec 15; 17(4):245-53. PubMed ID: 8946206
    [Abstract] [Full Text] [Related]

  • 10. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
    Yin Z, Babaian RJ, Troncoso P, Strom SS, Spitz MR, Caudell JJ, Stein JD, Kagan J.
    Oncogene; 2001 Apr 26; 20(18):2273-80. PubMed ID: 11402322
    [Abstract] [Full Text] [Related]

  • 11. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu X, An Q, Zhang J, Tang P, Cheng S.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct 26; 36(5):367-71. PubMed ID: 12761947
    [Abstract] [Full Text] [Related]

  • 12. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
    Choi C, Cho S, Horikawa I, Berchuck A, Wang N, Cedrone E, Jhung SW, Lee JB, Kerr J, Chenevix-Trench G, Kim S, Barrett JC, Koi M.
    Genes Chromosomes Cancer; 1997 Nov 26; 20(3):234-42. PubMed ID: 9365830
    [Abstract] [Full Text] [Related]

  • 13. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
    Li JT, Fu L, Xia JC, Feng BJ, Mai SJ, Yu XJ, Huang LX, Feng QS, Pan ZZ, Zhan YQ.
    Ai Zheng; 2005 Nov 26; 24(11):1306-11. PubMed ID: 16552953
    [Abstract] [Full Text] [Related]

  • 14. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C, Frierson HF, Haggerty PF, Theodorescu D, Gregory CW, Dong JT.
    Genomics; 2001 Oct 26; 77(3):135-44. PubMed ID: 11597138
    [Abstract] [Full Text] [Related]

  • 15. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
    Fromont G, Valeri A, Cher M, Pontes JE, Vallancien G, Validire P, Latil A, Cussenot O.
    Prostate; 2005 Dec 01; 65(4):341-6. PubMed ID: 16015610
    [Abstract] [Full Text] [Related]

  • 16. Definition and refinement of chromosome 8p regions of loss of heterozygosity in gastric cancer.
    Baffa R, Santoro R, Bullrich F, Mandes B, Ishii H, Croce CM.
    Clin Cancer Res; 2000 Apr 01; 6(4):1372-7. PubMed ID: 10778965
    [Abstract] [Full Text] [Related]

  • 17. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D, Gutiérrez JA, Rosenblum ML, Newsham IF, Bögler O, Rempel SA, NABTT CNS Consortium.
    Clin Cancer Res; 2003 Oct 01; 9(12):4435-42. PubMed ID: 14555516
    [Abstract] [Full Text] [Related]

  • 18. Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1.
    Zenklusen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ.
    Cancer Res; 1994 Dec 15; 54(24):6370-3. PubMed ID: 7987830
    [Abstract] [Full Text] [Related]

  • 19. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
    Fiedler U, Ehlers W, Meye A, Füssel S, Faller G, Schmidt U, Wirth MP.
    Anticancer Res; 2001 Dec 15; 21(4A):2341-50. PubMed ID: 11724291
    [Abstract] [Full Text] [Related]

  • 20. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM, Welch J, Hayward NK.
    Cancer Res; 2001 Feb 01; 61(3):1154-61. PubMed ID: 11221846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.